Eagle Health Investments LP
Source: SEC Form 13F · as of Mar 2026Eagle Health Investments LP holds 12 biotech & pharma companies tracked by BioSniper, totaling $244.7M in value as of Mar 2026 (SEC Form 13F).
Companies held
12
Total value held
$244.7M
BioSniper AIPage evidence connected
Prepared research question
What matters most for ARGENX SE (ARGX)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| ARGXARGENX SE | 76,336 | $55.7M |
| INSMINSMED Inc | 224,271 | $36.7M |
| BMRNBIOMARIN PHARMACEUTICAL INC | 505,809 | $28.6M |
| SRRKScholar Rock Holding Corp | 494,019 | $24.3M |
| TERNTerns Pharmaceuticals, Inc. | 412,497 | $21.7M |
| BBIOBridgeBio Pharma, Inc. | 267,031 | $19.8M |
| PTGXProtagonist Therapeutics, Inc | 179,322 | $18.9M |
| RVMDREVOLUTION MEDICINES, INC. | 119,464 | $11.6M |
| CMPSCOMPASS Pathways plc | 2,060,427 | $11.4M |
| CNTACentessa Pharmaceuticals plc | 214,291 | $8.5M |
| ATAIAtai Beckley N.V. | 1,709,359 | $6.1M |
| IMCRImmunocore Holdings plc | 46,300 | $1.4M |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.